Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I ...
Compare up to three stocks to (MPC-C.TO) by adding the symbol or company name.
A hepatocyte growth factor antagonist engineered by site-directed mutagenesis. This is an ASCO Meeting Abstract from the 2011 ASCO Annual Meeting I. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results